Skip to main content

Time in Range News

Time in Range (TIR) is the percentage of time that a person spends with their blood glucose levels in the target range, usually between 70 and 180 mg/dl.

A clinical trial by Lilly is seeing if your Time in Range could improve from taking Lyumjev, a ultra-rapid mealtime insulin, along with long acting insulin glargine.
Dr. Diana Isaacs on improving time in range, making the most of your data, and the barriers facing people with diabetes and their healthcare teams
If you are currently taking three or more insulin injections per day, you may be eligible to participate in a clinical trial that provides you with the Guardian Connect...
Chronic kidney disease is a major complication associated with diabetes that can lead to inaccurate A1C measurements. Here we explain why this is and what you can do to...
Keeping glucose levels in a tight range is more important than ever during pregnancy. Dr. Sarit Polsky discusses glucose management and target glucose levels, as well as...
More time in range and lower stress! In this Trial Watch, Kerri Sparling shares her experience with Tandem's Control-IQ
GMI provides an estimated A1C level based on continuous glucose monitoring data and can avoid some of the limitations of A1C tests. A recent study compared actual A1C...
Insulet’s Omnipod 5 automated insulin delivery system was shown to be effective, safe, and easy to use for adults, teens, and children with type 1 diabetes. Early...
Michael writes about how he used two main strategies – intermittent fasting and walking after meals ­– to put his type 2 diabetes into remission
Diabeloop’s AID system can improve Time in Range and quality of life for people with type 1 diabetes. Read below to learn more.
The recent release of clinical trial results shows that Omnipod 5, an automated insulin delivery (AID) system, can significantly increase Time in Range and reduce stress...
Results from recent clinical trials have shown that GLP-1 receptor agonist medications are effective at lowering A1C and body weight.
diaTribe is excited to bring you additional expanded coverage from the EASD 2021 virtual conference this past week! Find out more from leading clinicians and researchers...
diaTribe partnered with Abbott and Novo Nordisk to bring you the Time in Range Hub – a new online resource to help you and your healthcare providers learn about Time in...
Studies show that if you have diabetes, increasing your Time in Range (TIR) can lower your risk of developing kidney disease. Learn how kidney disease is diagnosed, why...
Quality measures are tools to evaluate the effectiveness and quality of healthcare. Measures such as A1C, blood pressure, and cholesterol are used to understand health...
A survey jointly conducted by diabetes research company dQ&A and The diaTribe Foundation assessed how well endocrinologists understood Time in Range and which...
Julie Heverly describes one harrowing day when her glucose levels teetered between way too high and way too low and how she navigated this challenge.
diaTribe’s Community Manager Cherise Shockley led an online discussion about Time in Range with Shay Webb, a diabetes advocate, and Julia Blanchette, a diabetes care and...
The Association of Diabetes Care and Education Specialists 2021 conference covered the impacts of diabetes stigma, smart MDI therapies, insulin delivery by means other...

Pages